mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.2 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.2 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |